Intellia Therapeutics is trading 5.14% up now at $13.08 on August 21, 2026, with the specific catalyst unconfirmed.
- No new company-specific announcement or regulatory catalyst was identified in its latest press-release listings.
- Its most recent major update was second-quarter results released August 6.
- The biotech sector is lower; the gain does not clearly align with sector performance and may reflect reversal buying or positioning after recent volatility.